About EndObetes
EndObetes is a company based in New York (United States) founded in 2015 by Marc Bessler. EndObetes offers products and services including Endoscopic Devices. EndObetes operates in a competitive market with competitors including Olympus, Fractyl, GI Windows, SurgiQuest and Eximis Surgical, among others.
- Headquarter New York, United States
- Founders Marc Bessler
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$250.59 K (USD), Grant
Jul 07, 2020
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EndObetes
EndObetes offers a comprehensive portfolio of products and services, including Endoscopic Devices.
Non-surgical devices for obesity and diabetes management through GI tract fixation.
Funding Insights of EndObetes
Investors in EndObetes
EndObetes has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Biotechnology Innovation Organization and MedTech Innovator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Locked | Locked | Locked | |
|
Consulting in business development and communication is provided for biopharma.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for EndObetes
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndObetes
Investment portfolio details for EndObetes
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EndObetes
Detailed financials for EndObetes
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endobetes Comparisons
Peer comparison for EndObetes
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndObetes
EndObetes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Fractyl, GI Windows, SurgiQuest and Eximis Surgical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| Locked | Locked | Locked |
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
|
|
| Locked | Locked | Locked |
Products for minimally invasive surgery are developed and supplied.
|
|
| Locked | Locked | Locked |
Minimal invasive specimen removal tools
|
|
| Locked | Locked | Locked |
Minimally invasive systems for laparoscopic surgery are developed.
|
Detailed competitors of EndObetes
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endobetes
Complete news archive for EndObetes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndObetes
EndObetes was founded in 2015 and raised its 1st funding round 4 years after it was founded.
EndObetes is headquartered in New York, United States. It is registered at New York, New York, United States.
EndObetes was founded in 2015 in New York, United States, within the medical device sector focused on gastrointestinal interventions. A surgical access tool has been created to address obesity and diabetes through endoscopic delivery. The device is positioned in the GI tract to route undiluted food directly to the small intestine, replicating gastric bypass effects. Operations center on tool development and potential clinical applications in bariatric care.
EndObetes's top competitors include Olympus, Fractyl and GI Windows.
EndObetes offers Endoscopic Devices.
EndObetes has 3 investors. Key investors include HHS, Biotechnology Innovation Organization, and MedTech Innovator.